Jan A. Lubinski

5Department Of Genetics And Pathology, Połabska 4 St
Szczecin, ZP 70115, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 505 publications

Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men.

Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men.

Journal: Hereditary cancer in clinical practice

Published: May 13, 2026

The Potential Role of Vitamin D in BRCA1 Pathogenic Variant Carriers: A Narrative Review.

The Potential Role of Vitamin D in BRCA1 Pathogenic Variant Carriers: A Narrative Review.

Journal: International journal of molecular sciences

Published: May 12, 2026

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 28, 2026

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

Journal: Journal of the National Cancer Institute

Published: February 25, 2026

Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk: MKI67 rs11016073 and APOB rs1367117 in a Female Prospective Cohort.

Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk: MKI67 rs11016073 and APOB rs1367117 in a Female Prospective Cohort.

Journal: International journal of molecular sciences

Published: January 03, 2026

All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast Cancers.

All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast Cancers.

Journal: International journal of molecular sciences

Published: December 27, 2025

PCSK9 rs562556 variant and survival in BRCA1 mutation carriers and mutation-negative familial breast cancer.

PCSK9 rs562556 variant and survival in BRCA1 mutation carriers and mutation-negative familial breast cancer.

Journal: NPJ breast cancer

Published: December 06, 2025

Ultra-Trace Blood Concentrations of Blood Serum Arsenic and Breast, Prostate and Colorectal Cancer Risks in the EPIC-Heidelberg Cohort.

Ultra-Trace Blood Concentrations of Blood Serum Arsenic and Breast, Prostate and Colorectal Cancer Risks in the EPIC-Heidelberg Cohort.

Journal: Cancers

Published: December 04, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Research square

Published: November 19, 2025

Familial colorectal cancer: search for novel predisposition genes.

Familial colorectal cancer: search for novel predisposition genes.

Journal: Human genomics

Published: November 12, 2025

Hereditary cancer: Germline testing practices across ERN GENTURIS member countries.

Hereditary cancer: Germline testing practices across ERN GENTURIS member countries.

Journal: European journal of human genetics : EJHG

Published: October 31, 2025

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Journal: European urology

Published: October 23, 2025

Showing 1-12 of 505

Last Updated: 09/26/2026